Success Metrics

Clinical Success Rate
100.0%

Based on 20 completed trials

Completion Rate
100%(20/20)
Active Trials
4(11%)
Results Posted
10%(2 trials)

Phase Distribution

Ph not_applicable
17
49%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution17 total trials
N/ANon-phased studies
17(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

95.2%

20 of 21 finished

Non-Completion Rate

4.8%

1 ended early

Currently Active

4

trials recruiting

Total Trials

35

all time

Status Distribution
Active(6)
Completed(20)
Terminated(1)
Other(8)

Detailed Status

Completed20
unknown8
Recruiting3
Not yet recruiting2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
35
Active
4
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A17 (100.0%)

Trials by Status

unknown823%
not_yet_recruiting26%
withdrawn13%
active_not_recruiting13%
recruiting39%
completed2057%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT04703114Not Applicable

Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)

Completed
NCT04578509

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

Completed
NCT06044051Not Applicable

Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma

Recruiting
NCT04355533Not Applicable

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Completed
NCT07166744Not Applicable

Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies

Not Yet Recruiting
NCT04078997

An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi

Completed
NCT04574765

A Research Platform to Screen Healthcare Workers- Coordinated Approach to Pandemic Trials of COVID-19

Completed
NCT06917261Not Applicable

Evaluation of the Diagnostic Performance of the TestNPass DM-DIV for SARS-CoV-2 Using a Nasopharyngeal Sample

Not Yet Recruiting
NCT06643039Not Applicable

Nosocomial Respiratory Virus Infection

Recruiting
NCT05897879Not Applicable

Impact of Bacterial Expression and Immune Response in the Severity of Pertussis

Recruiting
NCT04408014

Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Completed
NCT04557046Not Applicable

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test

Unknown
NCT05162508

Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe Disease

Unknown
NCT05114902

PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study

Unknown
NCT02851771Not Applicable

Improving the Diagnosis of Pneumonia in Emergency Rooms

Completed
NCT02858687Not Applicable

Improving the Diagnosis of Tonsillitis in Emergency Rooms

Completed
NCT02858609Not Applicable

Improving the Diagnosis of Diarrhoea in Emergency Rooms

Completed
NCT02858661Not Applicable

Improving the Diagnosis of Meningitis in Emergency Rooms

Completed
NCT05506618Not Applicable

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)

Unknown
NCT03698084

RESCEU: Defining the Burden of RSV Disease

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
35